NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...
Please provide your email address to receive an email when new articles are posted on . The Apollo TMS device was previously FDA cleared for treating MDD in adults. TMS offers a non-pharmacologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback